Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Theoretical Biology and Medical Modelling

Fig. 3

From: Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa

Fig. 3

A comparison of the observed and expected percentage prevalence for the model with different combination therapy. Prevalence is averaged over the different combination therapies observed in the data, that is, D1 = D4T-3TC-EFV, D2 = AZT-3TC-EFV, D3 = D4T-3TC-NVP, D4 = AZT-3TC-NVP, D5 = FTC-TDF-EFV, D6 = AZT-3TC-LPV/r, D7 = Other combinations

Back to article page